🔗 Share this article

This year's prestigious award in Physiology or Medicine was awarded for transformative discoveries that illuminate how the immune system targets harmful infections while protecting the body's own cells.

A trio of esteemed researchers—Japan's Prof. Sakaguchi and American scientists Dr. Brunkow and Dr. Ramsdell—received this honor.

The research identified specialized "sentinels" within the defense system that eliminate rogue defense cells capable of harming the organism.

The findings are now paving the way for new treatments for immune disorders and cancer.

These winners will share a prize fund valued at 11 million Swedish kronor.

Crucial Findings

"The work has been essential for understanding how the immune system functions and the reason we do not all suffer from severe autoimmune diseases," commented the head of the award panel.

This trio's studies address a core mystery: How does the immune system defend us from countless infections while keeping our healthy cells unharmed?

Our body's protection system uses white blood cells that search for signs of disease, even pathogens and bacteria it has not met before.

Such defenders utilize sensors—called recognition units—that are produced by chance in a vast number of variations.

That gives the immune system the ability to fight a wide array of invaders, but the randomness of the mechanism inevitably produces white blood cells that may target the body.

Security Guards of the Immune System

Scientists previously understood that some of these harmful white blood cells were destroyed in the immune organ—the site where immune cells develop.

The latest award recognizes the discovery of T-reg cells—known as the body's "peacekeepers"—which travel through the system to neutralize other immune cells that assault the body's own tissues.

It is known that this mechanism fails in self-attack conditions such as juvenile diabetes, multiple sclerosis, and RA.

The Nobel panel added, "The findings have laid the foundation for a novel area of investigation and spurred the development of innovative treatments, for instance for tumors and autoimmune diseases."

Regarding malignancies, regulatory T-cells block the system from attacking the growth, so research are focused on lowering their quantity.

In autoimmune diseases, trials are exploring increasing T-reg cells so the organism is not under attack. A similar approach could also be effective in reducing the chances of transplanted organ failure.

Innovative Experiments

Professor Sakaguchi, from a Japanese institution, performed tests on rodents that had their thymus removed, causing self-attack conditions.

The researcher demonstrated that injecting immune cells from other animals could prevent the illness—implying there was a system for preventing defenders from harming the host.

Mary Brunkow, from the Institute for Systems Biology in a US city, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were studying an genetic immune disorder in mice and people that resulted in the discovery of a genetic factor critical for how regulatory T-cells function.

"The pioneering work has revealed how the body's defenses is controlled by T-reg cells, preventing it from accidentally attacking the body's own tissues," commented a prominent biological science specialist.

"The work is a striking illustration of how basic physiological research can have broad consequences for public health."